mAb
Rituximab
Rituximab is an anti-CD20 monoclonal antibody used in B-cell lymphomas and autoimmune disease. BOOKPHARM supplies rituximab biosimilar through technology transfer and drug-substance supply.
Supply offerings
| Business line | Business model | Regulatory status |
|---|---|---|
| APImAb | Tech Transfer + Supply | NMPA approval |
Supplied for pharmaceutical manufacturing and R&D by licensed and qualified entities. Not for human use as supplied. Availability is subject to regulatory approval in the buyer's jurisdiction.